Quanta, IDT Sign Deal for Manufacture of microRNA Assays | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Quanta BioSciences today announced a partnership with Integrated DNA Technologies for the manufacture of assays for quantifying microRNAs.

Under the terms of the deal, IDT will produce the assays and market them through an online catalog directly to customers of Quanta.

Financial and other terms of the deal were not disclosed.

Based in Gaithersburg, Md., Quanta develops reagents for PCR, qPCR, and cDNA applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: certain genes repressed during memory formation, analysis of genomes from single neurons, and more.

NASA plans to test whether DNA sequencing studies can be conducted in microgravity.

Congress passes a continuing resolution to keep the US federal government funded through mid-December.

The Human Genome Project was launched 25 years ago, and at Nature, Francis Collins, James Watson, and Eric Green look back at the lessons learned.